Natco Pharma Schedules Investor Call for FY26 Audited Results
Natco Pharma Limited announced it will hold an earnings call for investors and analysts on Friday, May 29, 2026. The call, set for 4:30 PM Indian Standard Time (IST), will cover the company's audited financial results for both the fourth quarter and the full fiscal year ending March 31, 2026.
Key Financials Discussion
This investor call is a significant event for stakeholders to gain clarity on Natco Pharma's financial health and operational performance over the past fiscal year. Management will present the audited results and offer insights into the company's strategic direction and future prospects.
Management Team to Present
Senior executives scheduled to attend and discuss the results include:
- Mr. Rajeev Nannapaneni, Vice-chairman and CEO
- Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences
- Mr. Amit Parekh, Chief Financial Officer (CFO)
Call Details Announced
The earnings call is scheduled for Friday, May 29, 2026, at 16:30 IST. Participants can join via dial-in numbers for India, which include +91 22 6280 1222 and +91 22 7115 8123. International dial-in numbers and a Diamond Pass™ option are also available. For inquiries, interested parties can contact rohit.bhat@bksec.com.
